Species differences in the in vitro metabolic reduction of the amphetamine metabolite, 1-phenyl-2-propanone
- 1 September 1978
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 30 (1) , 415-418
- https://doi.org/10.1111/j.2042-7158.1978.tb13277.x
Abstract
Marked differences were observed, in the ability of fortified 9000 g liver homogenate supernatants from three species to reduce 1-phenyl-2-propanone to the corresponding alcohol. This metabolic keto-reduction was negligible in homogenates from the rat and extensive in the rabbit; guinea-pig liver homogenates had intermediate ability. Metabolic oxidation of 1-phenyl-2-propanol was negligible in all three species. The amount of deamination of amphetamine and of N-n-propylamphetamine was approximately equal, in vitro, in rats and guinea-pigs but two to three times greater in liver homogenates from rabbits. Approximately three times more deaminated products were formed from the in vitro metabolism of N-n-propylamphetamine than from amphetamine metabolism by all three species.This publication has 16 references indexed in Scilit:
- The identification and quantitation of the major metabolites of ethylamphetamine, produced by rabbit liver microsomal preparationsJournal of Pharmacy and Pharmacology, 1977
- Metabolism in vitro of n-methylamphetamine with rat liver homogenatesBiochemical Pharmacology, 1977
- In vitro metabolism of l-phenyl-2-(n-propylamino) propane (N-propylamphetamine) by rat liver homogenatesJournal of Pharmacy and Pharmacology, 1976
- The Metabolism of Amphetamines in MammalsDrug Metabolism Reviews, 1976
- The mechanism of oxidation of amphetamine enantiomorphs by liver microsomal preparations from different speciesJournal of Pharmacy and Pharmacology, 1972
- Phenylacetone oxime—An intermediate in the oxidative deamination of amphetamineBiochemical Pharmacology, 1971
- The metabolic fate of amphetamine in man and other speciesBiochemical Journal, 1970
- Urinary excretion of the drug and its main metabolite in man, after the administration of (±)-, (+)- and (-)-ethylamphetamineJournal of Pharmacy and Pharmacology, 1969
- The fate of amphetamine in man and other mammalsJournal of Pharmacy and Pharmacology, 1966
- Transannular Nitrogen-Carbonyl Interaction in Cyclic Aminoketones and Optical Rotatory Dispersion1,2Journal of the American Chemical Society, 1958